首页> 外文期刊>Journal of Evidence-Based Integrative Medicine >Silymarin, Olibanum, and Nettle, A Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial
【24h】

Silymarin, Olibanum, and Nettle, A Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial

机译:Silymarin,Olibanum和Nettle,一种混合草药制剂,治疗II型糖尿病:随机,双盲,安慰剂控制,临床试验

获取原文
获取外文期刊封面目录资料

摘要

Silybum marianum (L) Gaertn (milk thistle) seeds, Urtica dioica L (nettle) leaves, and Boswellia serrata (olibanum gum) resin are used traditionally by Iranian diabetic patients. The aim of this study was to evaluate the antihyperglycemic effects of these herbs in an herbal formulation in patients with type II diabetes mellitus. Sixty patients diagnosed as type II diabetes mellitus with fasting blood glucose level from 150 to 180 mg/dL, glycosylated hemoglobin level from 7.5% to 8.5%, and on oral antihyperglycemic drugs, were allocated to receive the mix herbal formulation or placebo for 90 days in a double-blind randomized placebo-controlled clinical trial. The mean serum fasting blood glucose, glycosylated hemoglobin, and triglyceride in the herbal drug group were significantly less than placebo group’s values after 3 months of the intervention. The study showed a potential antihyperglycemic and triglyceride lowering effect of the herbal formulation, while it did not have any significant cholesterol or blood pressure lowering effect.
机译:Silybum Marianum(L)Gaertn(牛奶蓟)种子,Urtica Dioica L(荨麻)叶子和Boswentia Serrata(橄榄色胶)树脂由伊朗糖尿病患者使用。本研究的目的是评估患有II型糖尿病患者的草药制剂中这些草药的抗血糖作用。六十名患者被诊断为II型糖尿病,血糖水平从150-180mg / dL,糖基化血红蛋白水平从7.5%〜8.5%,以及口服抗血血病药物,分配给接受混合物草药制剂或安慰剂90天在双盲随机安慰剂控制临床试验中。在干预3个月后,草药药物中,草药药物中的平均血清空腹血糖,糖基化血红蛋白和甘油三酯显着低于安慰剂组的价值。该研究显示出潜在的抗血糖和甘油三酯降低草药制剂的效果,而它没有任何显着的胆固醇或血压降低效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号